Preprint / Version 1

Different Dietary Patterns and their Effects on Alzheimer’s Disease

Authors

  • Inchara Baikady American High School

DOI:

https://doi.org/10.58445/nhay8f23

Keywords:

Alzheimer's, Nutrigenomics, neurobiology

Abstract

Alzheimer's disease (AD) is among the most common neurodegenerative diseases worldwide, yet the factors that drive it remain misunderstood. Growing evidence links diet, obesity, and the gut-brain axis to neurodegeneration, and three genes involved in metabolism and amyloid biology (SIRT1, APP, and LEP) correlated with diet. This review examines what is known about how four dietary patterns affect brain health: the US Western diet, the Japanese diet, the Mediterranean (including MIND) diet, and intermittent fasting. The United States and Japan, two high-income countries with very different diets, are compared directly using food-group intake, ultra-processed food intake (USA 55.0%, Japan 38.2% of calories), obesity rate, life expectancy, and early-onset dementia prevalence. Japan has a comparatively older population and therefore a higher all-age dementia prevalence than the United States, despite having a lower early-onset dementia prevalence. The Mediterranean diet and intermittent fasting are discussed through clinical, observational, and laboratory research rather than population data. These findings are hypothesis-generating and motivate gene-expression and longitudinal studies of diet, obesity, and brain health.

References

“2026 Alzheimer’s Disease Facts and Figures.” Alzheimer’s & Dementia, vol. 22, no. 4, Apr. 2026, https://doi.org/10.1002/alz.71345. Accessed 26 Oct. 2026.

American Society for Nutrition. “Living the Mediterranean Lifestyle.” American Society for Nutrition, 7 Jan. 2016, nutrition.org/living-mediterranean-lifestyle/. Accessed 26 Oct. 2026.

Anton, Stephen D, et al. “Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting.” Obesity (Silver Spring, Md.), vol. 26, no. 2, 2018, pp. 254–68, https://doi.org/10.1002/oby.22065.

“APP Gene: MedlinePlus Genetics.” Medlineplus.Gov, 11 Apr. 2022, medlineplus.gov/genetics/gene/app/. Accessed 26 Oct. 2026.

Awata, Shuichi, et al. “Prevalence and Subtype Distribution of Early-Onset Dementia in Japan.” Psychogeriatrics : The Official Journal of the Japanese Psychogeriatric Society [England], vol. 20, no. 6, Nov. 2020, pp. 817–23. PubMed, https://doi.org/10.1111/psyg.12596. Accessed 26 Oct. 2026.

Bao, Jian, et al. “High Fat Diet Mediates Amyloid-Β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.” Journal of Alzheimer’s Disease : JAD [United States], vol. 85, no. 2, 2022, pp. 863–76. PubMed, https://doi.org/10.3233/JAD-215299. Accessed 26 Oct. 2026.

Barnes, Lisa L, et al. “Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons.” The New England Journal of Medicine, vol. 389, no. 7, July 2023, https://doi.org/10.1056/nejmoa2302368.

Behera, Deepak Kumar, et al. “Alzheimer’s Disease and Dementia in Japan: Epidemiological Trends, Regional Disparities, and Future Projections.” Alzheimer’s & Dementia, vol. 21, no. 7, July 2025, https://doi.org/10.1002/alz.70444. Accessed 26 Oct. 2026.

Beveridge, Jordan, et al. “Intermittent Fasting and Neurocognitive Disorders: What the Evidence Shows.” The Journal of Nutrition, Health and Aging, vol. 29, no. 4, Jan. 2025, p. 100480, https://doi.org/10.1016/j.jnha.2025.100480. Accessed 27 Oct. 2026.

Biochemical Pharmacology. “Neurofibrillary Tangle - an Overview | ScienceDirect Topics.” Www.Sciencedirect.Com, 2014, www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/neurofibrillary-tangle. Accessed 26 Oct. 2026.

Bonda, David J., et al. “The Critical Role of the Sirtuin Pathway in Aging and Alzheimer Disease: Mechanistic and Therapeutic Considerations.” Lancet Neurology, vol. 10, no. 3, Mar. 2011, pp. 275–79, https://doi.org/10.1016/S1474-4422(11)70013-8. Accessed 26 Oct. 2026.

Centers for Disease Control and Prevention. “National Health and Nutrition Examination Survey.” National Health and Nutrition Examination Survey, 30 Dec. 2024, www.cdc.gov/nchs/nhanes/index.html. Accessed 26 Oct. 2026.

Chen, Jennifer, et al. “SIRT1 Protects Against Microglia-Dependent Amyloid-Beta Toxicity Through Inhibiting NF-kappaB Signaling.” The Journal of Biological Chemistry, vol. 280, no. 48, Dec. 2005, pp. 40364–74, https://doi.org/10.1074/jbc.M509329200. Accessed 27 Oct. 2026.

Chávez-Castillo, Mervin, et al. “Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer’s Disease.” Molecules, vol. 30, no. 15, July 2025, pp. 3057–57, https://doi.org/10.3390/molecules30153057.

Cicerale, Sara, et al. “Biological Activities of Phenolic Compounds Present in Virgin Olive Oil.” International Journal of Molecular Sciences, vol. 11, no. 2, Feb. 2010, pp. 458–79, https://doi.org/10.3390/ijms11020458.

Cole, Greg M., and Sally A. Frautschy. “DHA May Prevent Age-Related Dementia.” The Journal of Nutrition, vol. 140, no. 4, Feb. 2010, pp. 869–74, https://doi.org/10.3945/jn.109.113910.

“Faostat.” Fao.Org, 2026, www.fao.org/faostat/en/? Accessed 26 Oct. 2026.

Flores-Cordero, Juan Antonio, et al. “Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin.” International Journal of Molecular Sciences, vol. 23, no. 9, May 2022, p. 5202, https://doi.org/10.3390/ijms23095202.

Galizzi, Giacoma. “Omega-3 Fatty Acids and Alzheimer’s Disease: Toward a New Understanding of Neuroprotective Mechanisms and Intervention Strategies.” Marine Drugs [Switzerland], vol. 24, no. 7, June 2026, p. 224. PubMed Central, https://doi.org/10.3390/md24070224. Accessed 26 Oct. 2026.

Garegnani, Luis I, et al. “Intermittent Fasting for Adults With Overweight or Obesity.” Cochrane Database of Systematic Reviews, edited by Cochrane Central Editorial Service, vol. 2026, no. 2, no. CD015610, Feb. 2026, https://doi.org/10.1002/14651858.cd015610.pub2. Accessed 26 Oct. 2026.

Gudden, Jip, et al. “The Effects of Intermittent Fasting on Brain and Cognitive Function.” Nutrients, vol. 13, no. 9, Sept. 2021, p. 3166, https://doi.org/10.3390/nu13093166.

Hamilton, Kirsty, and Jenni Harvey. “The Neuronal Actions of Leptin and the Implications for Treating Alzheimer’s Disease.” Pharmaceuticals, vol. 14, no. 1, Jan. 2021, https://doi.org/10.3390/ph14010052. Accessed 26 Oct. 2026.

Hidalgo-Moyano, Cristina, et al. “Diet and SIRT1 Genotype Interact to Modulate Aging-Related Processes in Patients With Coronary Heart Disease: From the CORDIOPREV Study.” Nutrients [Switzerland], vol. 14, no. 18, Sept. 2022, p. 3789. PubMed Central, https://doi.org/10.3390/nu14183789. Accessed 27 Oct. 2026.

Husain, Mohammed Amir, et al. “APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics.” Frontiers in Neuroscience, vol. 15, Feb. 2021, https://doi.org/10.3389/fnins.2021.630502. Accessed 26 Oct. 2026.

Kimura, Yasumi, et al. “Long-Term Association of Vegetable and Fruit Intake With Risk of Dementia in Japanese Older Adults: The Hisayama Study.” BMC Geriatrics, vol. 22, no. 1, Mar. 2022, https://doi.org/10.1186/s12877-022-02939-2.

Koiwai, Kaori, et al. “Consumption of Ultra-Processed Foods Decreases the Quality of the Overall Diet of Middle-Aged Japanese Adults.” Public Health Nutrition, vol. 22, no. 16, June 2019, pp. 2999–3008, https://doi.org/10.1017/s1368980019001514. Accessed 26 Oct. 2026.

Lee, Hye Rin, et al. “Cilostazol Suppresses Β-Amyloid Production by Activating a Disintegrin and Metalloproteinase 10 via the Upregulation of SIRT1-Coupled Retinoic Acid Receptor-Β.” Journal of Neuroscience Research [United States], vol. 92, no. 11, Nov. 2014, pp. 1581–90. PubMed, https://doi.org/10.1002/jnr.23421. Accessed 26 Oct. 2026.

“LEP Gene: MedlinePlus Genetics.” Medlineplus.Gov, 1 Dec. 2013, medlineplus.gov/genetics/gene/lep/. Accessed 26 Oct. 2026.

Li, Xiaoling. “SIRT1 and Energy Metabolism.” Acta Biochimica et Biophysica Sinica, vol. 45, no. 1, Jan. 2013, pp. 51–60, https://doi.org/10.1093/abbs/gms108. Accessed 26 Oct. 2026.

Marwarha, Gurdeep, et al. “Leptin Reduces the Accumulation of Aβ and Phosphorylated Tau Induced by 27-Hydroxycholesterol in Rabbit Organotypic Slices.” Journal of Alzheimer’s Disease, vol. 19, no. 3, Jan. 2010, pp. 1007–19, https://doi.org/10.3233/jad-2010-1298.

Morris, Martha Clare, et al. “MIND Diet Associated With Reduced Incidence of Alzheimer’s Disease.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, vol. 11, no. 9, 2015, pp. 1007–14, https://doi.org/10.1016/j.jalz.2014.11.009. Accessed 26 Oct. 2026.

Murayama, Hiroshi, et al. “The Yabu Cohort Study: Design and Profile of Participants at Baseline.” Journal of Epidemiology [Japan], vol. 24, no. 6, 2014, pp. 519–25. PubMed, https://doi.org/10.2188/jea.je20140065. Accessed 26 Oct. 2026.

Muscogiuri, Giovanna, et al. “Mediterranean Diet and Obesity-Related Disorders: What Is the Evidence?” Current Obesity Reports, vol. 11, no. 4, Sept. 2022, https://doi.org/10.1007/s13679-022-00481-1.

National Institute on Aging. “What Do We Know About Diet and Prevention of Alzheimer’s Disease?” National Institute on Aging, 20 Nov. 2023, www.nia.nih.gov/health/alzheimers-and-dementia/what-do-we-know-about-diet-and-prevention-alzheimers-disease. Accessed 26 Oct. 2026.

“What Happens to the Brain in Alzheimer’s Disease?” National Institute on Aging, 19 Jan. 2024, www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/what-happens-brain-alzheimers-disease. Accessed 26 Oct. 2026.

National Institutes of Health. “NIH Study Finds Heavily Processed Foods Cause Overeating and Weight Gain.” National Institutes of Health (NIH), 17 June 2019, www.nih.gov/news-events/news-releases/nih-study-finds-heavily-processed-foods-cause-overeating-weight-gain. Accessed 26 Oct. 2026.

Niedowicz, Dana M, et al. “Leptin Regulates Amyloid Β Production via the Γ-Secretase Complex.” Biochimica et Biophysica Acta [Netherlands], vol. 1832, no. 3, Mar. 2013, pp. 439–44. PubMed Central, https://doi.org/10.1016/j.bbadis.2012.12.009. Accessed 26 Oct. 2026.

Obradovic, Milan, et al. “Leptin and Obesity: Role and Clinical Implication.” Frontiers in Endocrinology, vol. 12, no. 12, 2021, https://doi.org/10.3389/fendo.2021.585887. Accessed 26 Oct. 2026.

Palmer, Alan M. “Pharmacotherapy for Alzheimer’s Disease: Progress and Prospects.” Trends in Pharmacological Sciences, vol. 23, no. 9, Sept. 2002, pp. 426–33, https://doi.org/10.1016/s0165-6147(02)02056-4.

Pan, Rui-Yuan, et al. “Intermittent Fasting Protects Against Alzheimer’s Disease in Mice by Altering Metabolism Through Remodeling of the Gut Microbiota.” Nature Aging, vol. 2, no. 11, Nov. 2022, pp. 1024–39, https://doi.org/10.1038/s43587-022-00311-y. Accessed 27 Oct. 2026.

Pardo, Patricia S., and Aladin M. Boriek. “SIRT1 Regulation in Ageing and Obesity.” Mechanisms of Ageing and Development, vol. 188, June 2020, p. 111249, https://doi.org/10.1016/j.mad.2020.111249. Accessed 26 Oct. 2026.

Pedersen, S. B., et al. “Low Sirt1 Expression, Which Is Upregulated by Fasting, in Human Adipose Tissue From Obese Women.” International Journal of Obesity (2005) [England], vol. 32, no. 8, Aug. 2008, pp. 1250–55. PubMed, https://doi.org/10.1038/ijo.2008.78. Accessed 27 Oct. 2026.

QIU, W, and M FOLSTEIN. “Insulin, Insulin-Degrading Enzyme and Amyloid-Β Peptide in Alzheimer’s Disease: Review and Hypothesis.” Neurobiology of Aging, vol. 27, no. 2, Feb. 2006, pp. 190–98, https://doi.org/10.1016/j.neurobiolaging.2005.01.004.

Seidler, Karin, and Michelle Barrow. “Intermittent Fasting and Cognitive Performance – Targeting BDNF as Potential Strategy to Optimise Brain Health.” Frontiers in Neuroendocrinology, vol. 65, no. 1, Apr. 2022, p. 100971, https://doi.org/10.1016/j.yfrne.2021.100971.

Singh, Balwinder, et al. “Association of Mediterranean Diet With Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis.” Journal of Alzheimer’s Disease, vol. 39, no. 2, Jan. 2014, pp. 271–82, https://doi.org/10.3233/jad-130830.

Steele, Eurídice Martínez, et al. “Identifying and Estimating Ultraprocessed Food Intake in the US NHANES According to the Nova Classification System of Food Processing.” The Journal of Nutrition, vol. 153, no. 1, Jan. 2023, pp. 225–41, https://doi.org/10.1016/j.tjnut.2022.09.001. Accessed 26 Oct. 2026.

Sun, Ting, et al. “miR-30a-5p Induces Aβ Production via Inhibiting the Nonamyloidogenic Pathway in Alzheimer’s Disease.” Pharmacological Research [Netherlands], vol. 178, Apr. 2022, p. 106153. PubMed, https://doi.org/10.1016/j.phrs.2022.106153. Accessed 26 Oct. 2026.

Williams, Anne, et al. Ultra-Processed Food Consumption in Youth and Adults: United States, August 2021- August 2023. Aug. 2025, https://doi.org/10.15620/cdc/174612. Accessed 26 Oct. 2026.

Wong, David E, et al. “Pathophysiological Links Between Obesity and Dementia..” Neuromolecular Medicine, Apr. 2023, https://doi.org/10.1007/s12017-023-08746-1.

World Health Organization. “Dementia.” World Health Organization, 31 Mar. 2025, www.who.int/news-room/fact-sheets/detail/dementia. Accessed 26 Oct. 2026.

Zhang, Chenghao, et al. “Health Effects of Intermittent Fasting and the Role of Artificial Intelligence Technologies in Optimizing Its Clinical Translation.” AIMS Public Health, vol. 12, no. 4, 2025, pp. 1190–222, https://doi.org/10.3934/publichealth.2025061. Accessed 27 Oct. 2026.

Downloads

Posted

2026-11-01

Categories

License

Copyright (c) 2026 Research Archive of Rising Scholars

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.